外泌体 (Exosomes) 是纳米级的细胞外囊泡,直径通常约为 40-160 nm;它们源自内吞体途径,通过在供体细胞与受体细胞之间传递蛋白质、脂质、DNA、mRNA、microRNA 及其他生物活性物质,介导细胞间的通讯。Exosomes 集天然靶向能力、低免疫原性、生物相容性、长循环半衰期以及跨越生物屏障(包括血脑屏障)的能力于一身,使其成为癌症治疗、再生医学、疾病诊断及药物递送领域极具吸引力的平台。从机制上看,肿瘤来源的 Exosomes 通过细胞间信号传导来调控肿瘤的进展;通过将致癌性 miRNA、蛋白质及信号介质传递给基质细胞和免疫细胞,从而促进血管生成、上皮-间充质转化(EMT)、免疫逃逸、肿瘤转移以及转移前微环境的形成。此外,Exosomes 还能通过保护肿瘤细胞免受细胞毒性药物的侵害,并将耐药性特征传递给邻近细胞,从而诱导并加剧化疗耐药性的产生。
在药物研发领域,经过工程化修饰的 Exosomes 正被用作纳米载体,用于递送化疗药物、siRNA、miRNA、lncRNA、CRISPR 载荷以及免疫调节剂;在乳腺癌、肺癌、胶质瘤、结直肠癌及肝细胞癌等疾病模型中,这种策略在提高肿瘤靶向性的同时,有效降低了全身性毒性。此外,Exosomes 还用于组织修复、炎症性疾病调控、神经退行性疾病治疗以及基于“液体活检”技术的精准诊断;且循环 Exosomes 中所携带的生物标志物,有助于实现疾病的早期筛查与治疗效果的实时监测。
Exosomes are nanoscale extracellular vesicles, typically ranging in diameter from approximately 40 to 160 nm; originating from the endosomal pathway, they mediate intercellular communication by transferring proteins, lipids, DNA, mRNA, microRNA, and other bioactive substances between donor and recipient cells. Exosomes possess a unique combination of attributes-including natural targeting capabilities, low immunogenicity, biocompatibility, a long circulatory half-life, and the ability to traverse biological barriers (including the blood-brain barrier)-making them a highly attractive platform for applications in cancer therapy, regenerative medicine, disease diagnosis, and drug delivery. Mechanistically, tumor-derived exosomes regulate tumor progression through intercellular signaling; by delivering oncogenic miRNAs, proteins, and signaling mediators to stromal and immune cells, they promote angiogenesis, epithelial-mesenchymal transition (EMT), immune evasion, tumor metastasis, and the formation of a pre-metastatic niche. Furthermore, exosomes can induce and exacerbate chemotherapy resistance by shielding tumor cells from cytotoxic drugs and by transferring drug-resistance traits to neighboring cells.
In the field of drug development, engineered exosomes are being utilized as nanocarriers for the delivery of chemotherapeutic agents, siRNAs, miRNAs, lncRNAs, CRISPR payloads, and immunomodulators. In disease models involving breast cancer, lung cancer, glioma, colorectal cancer, and hepatocellular carcinoma, this strategy has effectively reduced systemic toxicity while simultaneously enhancing tumor-targeting specificity. Moreover, exosomes are being applied in tissue repair, the modulation of inflammatory diseases, the treatment of neurodegenerative disorders, and precision diagnostics based on "liquid biopsy" technologies; the biomarkers carried within circulating exosomes facilitate the early screening of diseases and the real-time monitoring of therapeutic efficacy.
GPLGVRGC 是一种半胱氨酸标记的 GPLGVRG (MS-Q28298),可被 MMP13 水解,并能介导胶束-外泌体系统拆解、增强软骨细胞内吞作用、促进响应性系统摄取,从而为胶束-外泌体系统赋予靶向递送和响应性释放特性,可用于骨关节炎的研究。
Monensin (Monensin A) 是一种具有口服活性的抗生素,也是一种介导 Na+/H+ 交换的离子载体,同时是一种有效的 Wnt 信号传导抑制剂,可导致多泡体(MVB)显著增大并调节外泌体分泌,可用于细菌、真菌和寄生虫感染研究,并显示出抗癌作用。
Monensin (Monensin A) sodium 是一种具有口服活性的抗生素,也是一种介导 Na+/H+ 交换的离子载体,同时是一种有效的 Wnt 信号传导抑制剂,可导致多泡体(MVB)显着增大并调节外泌体分泌,可用于细菌、真菌和寄生虫感染研究,并显示出抗癌作用。
Monensin (sodium) (Standard) 是 Monensin (sodium) 的分析标准品,本产品用于研究及分析应用,而 Monensin (Monensin A) sodium 是一种具有口服活性的抗生素,也是一种介导 Na+/H+ 交换的离子载体,同时是一种有效的 Wnt 信号传导抑制剂,可导致多泡体(MVB)显着增大并调节外泌体分泌,可用于细菌、真菌和寄生虫感染研究,并显示出抗癌作用。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号